Dictionary
The Dictionary provides concise definitions of health economics terms, arranged alphabetically for quick reference. Use it to understand unfamiliar terminology or confirm the meaning of a specific term.
T
- Tiered PricingTermPrice Tiering, Graduated Pricing
- A pricing strategy charging different prices for the same product across markets, typically calibrated to differences in ability to pay.
- Time DependencyConceptTime-Dependence, Temporal Dependence
- The property of a risk, effect, cost, utility or other model input changing according to a specified time scale, such as attained age or time since an event.
- Time HorizonConceptAnalytic Horizon, Evaluation Period
- The span of time over which an economic evaluation captures relevant differences in costs and outcomes among the options being compared.
- Time Horizon ChoiceTermHorizon Choice, Analytic Horizon Decision
- The methodological decision on how long a model should simulate costs and outcomes, informed by disease natural history and treatment effect duration.
- Time Horizon Selection HTATermHTA Time Horizon, Lifetime Horizon Selection
- The methodological decision on how long a cost-effectiveness analysis should simulate costs and outcomes, often requiring a full lifetime horizon for chronic conditions.
- Time on TreatmentTermToT, Duration on Therapy
- The duration a patient continues receiving a specific therapy before discontinuation, whether from progression, intolerable effects, or achieving the treatment goal.
- Time PreferenceConceptTemporal Discounting, Impatience Parameter
- Time preference is the preference for benefits sooner and costs later; in health economics it is one reason future costs and QALYs are discounted.
- Time Series DataTermTemporal Data, Time-Ordered Data
- Data consisting of repeated measurements of the same variable collected sequentially over time, such as monthly disease incidence rates.
- Time Series DesignTermTime Series Study, Serial Measurement Design
- A study design examining a sequence of observations on one population collected repeatedly over time, often to assess a policy's impact before and after.
- Time StepTermSimulation Step, Iteration Interval
- The fixed interval of time by which a discrete-time model, such as a Markov model, advances with each calculation.
- Time StructureTermTemporal Structure, Model Timing Framework
- The way a model represents the passage of time, whether in fixed discrete cycles, as in a Markov model, or continuously.
- Time to MarketTermSpeed to Market, Launch Timeline
- The total elapsed time from a drug candidate's discovery to regulatory approval and market availability, often spanning a decade or more.
- Time to ResponseTermResponse Time, Time until Response
- The interval between the start of treatment and the point a patient meets a defined responder threshold on a relevant outcome measure.
- Time Trade-OffConceptTTO, Life-Year Trade-Off
- A health state valuation method asking how many years in full health a respondent would consider equal to a longer period in an impaired state.
- Time Value of MoneyConceptTVM, Present Value Principle
- The principle that a given sum of money is worth more today than the same sum received in the future.
- Time with SymptomsTermSymptomatic Time, Time in Symptomatic State
- A phase within the Q-TWiST framework representing the period during which a patient experiences symptoms of disease progression or treatment toxicity.
- Time Without Symptoms of ProgressionConceptTWiST, Symptom-Free Progression-Free Time
- A phase within the Q-TWiST framework covering the period free of significant treatment toxicity or disease progression symptoms, typically weighted highest.
- Time-Driven Activity-Based CostingConceptTDABC, Time-Driven ABC
- A costing method estimating a service's cost by multiplying the capacity cost rate of resources involved by the time required to complete each activity.
- Time-Fixed CovariateTermBaseline Covariate, Time-Invariant Covariate
- A patient characteristic in a survival model measured once and assumed constant throughout follow-up, such as baseline age or sex.
- Time-Homogeneous ModelConceptTime-Constant Model, Stationary Markov Model
- A Markov model in which transition probabilities remain constant throughout the entire modelled time horizon, regardless of how many cycles have passed.
- Time-Inhomogeneous ModelConceptTime-Varying Markov Model, Non-Stationary Model
- A Markov model in which transition probabilities are allowed to vary over the time horizon, such as mortality risk rising with age.
- Time-to-EventConceptEvent-Time Outcome, Event-History Outcome
- Outcome data recording the duration until a specific event of interest occurs, such as disease progression or death, possibly censored.
- Time-Varying CovariateConceptTime-Dependent Covariate, Updating Covariate
- A patient characteristic in a survival model allowed to change value over follow-up, such as a repeatedly measured biomarker.
- Time-Varying HazardConceptTime-Dependent Hazard, Non-Constant Hazard
- A hazard rate that changes in magnitude over follow-up, unlike a constant hazard that stays the same at every point.
- Timely AccessTermPrompt Access, Timeliness of Care
- A healthcare access dimension concerning whether patients can obtain needed care within a clinically appropriate timeframe, including wait times.
- Tipping Point AnalysisTermTipping-Point Method, Switch-Point Analysis
- A missing data sensitivity technique searching for the specific departure from a standard assumption that would be needed to overturn a study's conclusion.
- TitrationTermDose Adjustment, Dose Ramping
- The process of gradually adjusting a medication's dose, usually starting low and increasing, to balance therapeutic effect against tolerability.
- TLVTermDental and Pharmaceutical Benefits Agency, Swedish Benefits Agency
- The Swedish Dental and Pharmaceutical Benefits Agency, determining which pharmaceuticals and dental services are subsidised based on cost-effectiveness assessment.
- Tobacco Control EconomicsTermEconomics of Tobacco Control, Smoking Control Economics
- The application of health economic evaluation to population-level tobacco policies, including taxation, advertising restrictions, and public smoking bans.
- Tobacco PolicyTermTobacco Control Policy, Anti-Smoking Policy
- Government policy aimed at reducing tobacco use, covering taxation, advertising restrictions, public smoking bans, and cessation programme funding.
- Tobacco Use PrevalenceTermSmoking Prevalence, Tobacco Prevalence
- A measure of the proportion of a population currently using tobacco products, a leading modifiable chronic disease risk factor.
- ToleranceTermDrug Habituation, Reduced Drug Response
- A regression diagnostic, one minus a predictor's coefficient of determination against all other predictors, detecting multicollinearity, lower values meaning more collinearity.
- Tolerance IntervalConceptCoverage Interval, Population Coverage Bound
- An interval calculated to contain a specified proportion of an entire population's values with a given confidence, unlike a confidence or prediction interval.
- Toll GoodsTermExcludable Non-Rival Goods, Toll Good
- Goods that are excludable but non-rivalrous within capacity, allowing a charge for access while extra users add little cost until congestion is reached.
- Top-Down Cost-of-IllnessTermPrevalence-Based Cost-of-Illness, Aggregate Cost-of-Illness
- A cost-of-illness study estimating disease-specific cost by apportioning a share of national or aggregate expenditure statistics to a particular condition.
- Top-Down CostingConceptMacro-Costing, Top-Level Costing
- A costing approach that starts with aggregate costs and allocates them to services, activities or patients using documented shares and output counts.
- Topic IdentificationTermTopic Scanning, Candidate Identification
- The initial process by which an assessment body identifies technologies or questions that may warrant formal assessment, from various sources.
- Topic NominationTermTopic Proposal, Assessment Nomination
- A formal proposal submitted suggesting that a specific technology or clinical question be selected for formal assessment.
- Topic PrioritisationTermTopic Ranking, Assessment Prioritisation
- The process of ranking candidate assessment topics by criteria such as clinical importance and budget impact, given limited assessment capacity.
- Topic SelectionTermAssessment Selection, Topic Decision
- The formal decision on which candidate technologies or questions will proceed to a full assessment, following identification and prioritisation.
- Topical AdministrationTermTopical Application, Local Administration
- A route of drug administration applying medication directly to the skin or another surface for local effect, common in dermatological conditions.
- Tornado DiagramConceptTornado Plot, Tornado Chart
- A horizontal bar chart displaying one-way sensitivity analysis results, bars ranked from largest to smallest range, resembling a tornado shape.
- Total CostTermAggregate Cost, Total Expenditure
- The sum of all costs, fixed and variable, incurred in producing a given level of output.
- Total Cost of CareTermTCOC, Total Care Cost
- A comprehensive measure of all healthcare spending associated with a defined population over a period, across all settings and providers.
- Total Effect IndexConceptTotal Sobol Index, Total-Order Index
- A variance-based sensitivity measure quantifying an input's total contribution to output variance, including its individual effect and all interactions with other inputs.
- Total Quality ManagementTermTQM, Organisation-Wide Quality Management
- A comprehensive organisational philosophy emphasising continuous improvement, customer focus, and employee engagement in identifying and addressing quality problems.
- Toxicology StudiesTermToxicology Testing, Preclinical Toxicology
- Research, typically in laboratory and animal models, characterising a drug candidate's potential harmful effects at various doses before human testing.
- Toxoplasmosis EconomicsTermEconomics of Toxoplasmosis, Toxoplasma Economics
- The application of health economic evaluation to toxoplasmosis, a parasitic infection posing particular risks to immunocompromised patients and fetal development.
- Trace ValidationTermTrace Checking, Patient-Path Checking
- The review of a Markov model's cohort trace, the proportion of a modelled population in each health state over time, for clinical plausibility.
- Traceable CostTermDirectly Attributable Cost, Assignable Cost
- A cost that can be directly attributed to a particular department, product, or service line without relying on an allocation method.